De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G (April 2004). „Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity”. Blood103 (7): 2452–9. DOI:10.1182/blood-2003-08-2857. PMID14525775.
Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (August 2003). „Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy”. Lancet362 (9385): 697–703. DOI:10.1016/S0140-6736(03)14232-8. PMID12957092.
Zheng H, Fu G, Dai T, Huang H (September 2007). „Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway”. J. Cardiovasc. Pharmacol.50 (3): 274–80. DOI:10.1097/FJC.0b013e318093ec8f. PMID17878755.
Kryczek I, Wei S, Keller E, Liu R, Zou W (March 2007). „Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis”. Am. J. Physiol., Cell Physiol.292 (3): C987–95. DOI:10.1152/ajpcell.00406.2006. PMID16943240.
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A (March 2001). „Involvement of chemokine receptors in breast cancer metastasis”. Nature410 (6824): 50–6. DOI:10.1038/35065016. PMID11242036.
Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A, Pfeffer U (September 2009). „CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival”. Eur. J. Cancer45 (14): 2579–87. DOI:10.1016/j.ejca.2009.06.026. PMID19646861.
Wendt MK, Cooper AN, Dwinell MB (February 2008). „Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells”. Oncogene27 (10): 1461–71. DOI:10.1038/sj.onc.1210751. PMID17724466.
Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (October 2005). „The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes”. J. Biol. Chem.280 (42): 35760–6. DOI:10.1074/jbc.M508234200. PMID16107333.
Shirozu M, Nakano T, Inazawa J, et al. (August 1995). „Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene”. Genomics28 (3): 495–500. DOI:10.1006/geno.1995.1180. PMID7490086.
Deloukas P, Earthrowl ME, Grafham DV, et al. (May 2004). „The DNA sequence and comparative analysis of human chromosome 10”. Nature429 (6990): 375–81. DOI:10.1038/nature02462. PMID15164054.
De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G (April 2004). „Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity”. Blood103 (7): 2452–9. DOI:10.1182/blood-2003-08-2857. PMID14525775.
Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (August 2003). „Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy”. Lancet362 (9385): 697–703. DOI:10.1016/S0140-6736(03)14232-8. PMID12957092.
Zheng H, Fu G, Dai T, Huang H (September 2007). „Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway”. J. Cardiovasc. Pharmacol.50 (3): 274–80. DOI:10.1097/FJC.0b013e318093ec8f. PMID17878755.
Kryczek I, Wei S, Keller E, Liu R, Zou W (March 2007). „Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis”. Am. J. Physiol., Cell Physiol.292 (3): C987–95. DOI:10.1152/ajpcell.00406.2006. PMID16943240.
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A (March 2001). „Involvement of chemokine receptors in breast cancer metastasis”. Nature410 (6824): 50–6. DOI:10.1038/35065016. PMID11242036.
Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A, Pfeffer U (September 2009). „CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival”. Eur. J. Cancer45 (14): 2579–87. DOI:10.1016/j.ejca.2009.06.026. PMID19646861.
Wendt MK, Cooper AN, Dwinell MB (February 2008). „Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells”. Oncogene27 (10): 1461–71. DOI:10.1038/sj.onc.1210751. PMID17724466.
Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (October 2005). „The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes”. J. Biol. Chem.280 (42): 35760–6. DOI:10.1074/jbc.M508234200. PMID16107333.
Shirozu M, Nakano T, Inazawa J, et al. (August 1995). „Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene”. Genomics28 (3): 495–500. DOI:10.1006/geno.1995.1180. PMID7490086.
Deloukas P, Earthrowl ME, Grafham DV, et al. (May 2004). „The DNA sequence and comparative analysis of human chromosome 10”. Nature429 (6990): 375–81. DOI:10.1038/nature02462. PMID15164054.